Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. - Université de Limoges Accéder directement au contenu
Article Dans Une Revue Annals of Pharmacotherapy Année : 2015

Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.

Edeltraut Kröger
  • Fonction : Auteur
Marie Mouls
  • Fonction : Auteur
Machelle Wilchesky
  • Fonction : Auteur
Mieke Berkers
  • Fonction : Auteur
Pierre-Hugues Carmichael
  • Fonction : Auteur
Rob van Marum
  • Fonction : Auteur
Patrick Souverein
  • Fonction : Auteur
Toine Egberts
  • Fonction : Auteur

Résumé

No worldwide pharmacovigilance study evaluating the spectrum of adverse drug reactions (ADRs) induced by cholinesterase inhibitors (ChEI) in Alzheimer's disease has been conducted since their emergence on the market. To describe ChEI related ADRs in Alzheimer's disease (donepezil, rivastigmine, and galantamine) and characterize their seriousness as reported by national pharmacovigilance systems to VigiBase, a World Health Organization International Drug Monitoring Program database, between 1998 and 2013. All ChEI RELATED REPORTS: , submitted to VigiBase between 1998 and 2013 from THE FIVE CONTINENTS: were extracted. Analyses were carried out for general, serious, and nonserious ADRs. A total of 18 955 reports (43 753 ADRs) FROM 58 COUNTRIES: were reported: 60.1% in women; mean age 77.4 ± 9.1 years. Most reports originated from Europe (47.6%) and North America (40.4%). Rivastigmine and donepezil were involved in MOST: reports (41.4% each). The most frequently reported ADRs were neuropsychiatric (31.4%), gastrointestinal (15.9%), general (11.9%), and cardiovascular (11.7%) disorders. During the 2006-2013 period, serious ADRs remained more often reported than nonserious ones; the most serious were neuropsychiatric (34.0%), general (14.0%), cardiovascular (12.1%), and gastrointestinal (11.6%) disorders. Medication errors were reported in 2.0% of serious cases. Death occurred in 2.3% of the reports. This international pharmacovigilance study highlights the ADR pattern induced by ChEIs. Neuropsychiatric events were the most frequently reported ADRs. Serious cardiovascular events were frequently reported, suggesting that their significance has probably been previously underestimated. Given the frailty of the patients and the frequent comedications, caution is advised before introducing a ChEI.
Fichier non déposé

Dates et versions

hal-01216405 , version 1 (16-10-2015)

Identifiants

  • HAL Id : hal-01216405 , version 1
  • PUBMED : 26324356

Citer

Edeltraut Kröger, Marie Mouls, Machelle Wilchesky, Mieke Berkers, Pierre-Hugues Carmichael, et al.. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.. Annals of Pharmacotherapy, 2015. ⟨hal-01216405⟩
70 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More